Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Receptor Interacting Protein (RIP) kinases in cancer
Kaylee Ermine, Jian Yu, Lin Zhang
Genes & Diseases (2021) Vol. 9, Iss. 6, pp. 1579-1593
Open Access | Times Cited: 20

Showing 20 citing articles:

Necrosulfonamide ameliorates intestinal inflammation via inhibiting GSDMD-medicated pyroptosis and MLKL-mediated necroptosis
Wenchang Yang, Kaixiong Tao, Yaxin Wang, et al.
Biochemical Pharmacology (2022) Vol. 206, pp. 115338-115338
Closed Access | Times Cited: 39
From Crypts to Cancer: A Holistic Perspective on Colorectal Carcinogenesis and Therapeutic Strategies
Ehsan Gharib, Gilles A. Robichaud
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9463-9463
Open Access | Times Cited: 9
Recent advances in the development of RIPK2 modulators for the treatment of inflammatory diseases
Anh‐Tuan Pham, Amanda Franceschini Ghilardi, Lijun Sun
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 21
Molecular mechanism and potential therapeutic targets of necroptosis and ferroptosis in Alzheimer's disease
Sara Chavoshinezhad, Elmira Beirami, Esmael Izadpanah, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115656-115656
Open Access | Times Cited: 15
Small-Molecule Receptor-Interacting Protein 1 (RIP1) Inhibitors as Therapeutic Agents for Multifaceted Diseases: Current Medicinal Chemistry Insights and Emerging Opportunities
Kunyu Shi, Jifa Zhang, Enda Zhou, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 22, pp. 14971-14999
Closed Access | Times Cited: 21
Leucine-rich repeat kinase 2 at a glance
Christiane Zhu, Susanne Herbst, Patrick A. Lewis
Journal of Cell Science (2023) Vol. 136, Iss. 17
Open Access | Times Cited: 9
The roles of long non-coding RNAs in the necroptotic signaling of colon cancer cells
Esra Bozgeyik, Haydar Bağış, İbrahim Bozgeyik, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 6, pp. 5021-5028
Closed Access | Times Cited: 7
Clinical Significance and Expression Pattern of RIP5 and VGLL4 in Clear Cell Renal Cell Carcinoma Patients Treated with Sunitinib
Tanja Tomić, Davor Tomić, Martina Vukoja, et al.
Biomedicines (2024) Vol. 12, Iss. 1, pp. 149-149
Open Access | Times Cited: 2
Stable RNA G-Quadruplex in the 5′-UTR of Human cIAP1 mRNA Promotes Translation in an IRES-Independent Manner
Aditya Singha Roy, Subhabrata Majumder, Partha Saha
Biochemistry (2024)
Closed Access | Times Cited: 1
Crystal structures of biogenic amine derivative Schiff bases, and these compounds modulatory effect on cell cycle arrest and cell death in lung cancer cells
Elif Şenkuytu, Derya Davarcı, Seda Mesci, et al.
Journal of Molecular Structure (2024) Vol. 1312, pp. 138418-138418
Closed Access | Times Cited: 1
The role of RIPK1 in chronic obstructive pulmonary disease
Aman Tiwari, Avtar Singh Gautam, Shivam Kumar Pandey, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104020-104020
Closed Access | Times Cited: 1
Administration of necrostatin-1 ameliorates glucocorticoid-induced osteonecrosis of the femoral head in rats
Min Feng, Ruirui Zhang, Mingming Zhang, et al.
Journal of Molecular Histology (2023) Vol. 54, Iss. 3, pp. 207-216
Closed Access | Times Cited: 3
Exploring positions 6 and 7 of a quinazoline-based scaffold leads to changes in selectivity and potency towards RIPK2/3 kinases
Mbilo Misehe, Marika Matoušová, Alexandra Dvořáková, et al.
European Journal of Medicinal Chemistry (2023) Vol. 260, pp. 115717-115717
Open Access | Times Cited: 3
Biomarker RIPK3 Is Silenced by Hypermethylation in Melanoma and Epigenetic Editing Reestablishes Its Tumor Suppressor Function
Sarah Arroyo Villora, Paula Silva, Tamara Zenz, et al.
Genes (2024) Vol. 15, Iss. 2, pp. 175-175
Open Access
Kinase inhibitors: 20 years of success and many new challenges and recent trends in their patents
Mourad A. M. Aboul‐Soud, Yazeed A. Al‐Sheikh, Hazem K. Ghneim, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 7, pp. 583-592
Closed Access
Differential effects of areca nut, tobacco, and lime on oral squamous cell carcinoma progression
Tarun Verma, Sonali Adhikari, Meenakshi Kandpal, et al.
Frontiers in Cancer Control and Society (2024) Vol. 2
Open Access
RIP1 inhibition reduces chondrocyte apoptosis through downregulating nuclear factor-kappa B signaling in a mouse osteoarthritis model
Hong Zhao, Chenzhong Wang, Bo Liu, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access
Analysis of alternative splicing in chicken macrophages transfected with overexpression/knockdown of RIP2 gene
Huan Li, Changhua Sun, Yunlong Li, et al.
Animal Biotechnology (2023), pp. 1-12
Closed Access
Design, Synthesis and Evaluation of Novel Thieno[2,3, <i>d</i>]Pyrimidine Derivatives as Potent and Specific RIPK2 Inhibitors
Mbilo Misehe, Michal Šála, Marika Matoušová, et al.
(2023)
Closed Access
Design, synthesis and evaluation of novel thieno[2,3d]pyrimidine derivatives as potent and specific RIPK2 inhibitors
Mbilo Misehe, Michal Šála, Marika Matoušová, et al.
Bioorganic & Medicinal Chemistry Letters (2023) Vol. 97, pp. 129567-129567
Open Access
Page 1

Scroll to top